期刊文献+

葛兰心宁软胶囊中绞股蓝皂苷A大鼠体内药代动力学研究 被引量:3

Pharmacokinetics of Gypenoside A in Glanxinning Soft Capsules in Rats
在线阅读 下载PDF
导出
摘要 目的:应用超高效液相色谱-质谱联用分析方法(UPLC-MS),建立葛兰心宁软胶囊中绞股蓝皂苷A的大鼠血浆中的定量分析方法。方法:测定大鼠口服葛兰心宁软胶囊内容物后,血液中绞股蓝皂苷A的血药浓度随时间的动态变化,用药动学统计软件DAS 3.0进行统计,计算药代动力学参数。结果:线性范围为10~500 ng·mL^-1(r=0.9984);高、中、低浓度的日内RSD分别为2.7%、2.6%、4.2%;日间RSD分别为2.4%、2.8%、3.1%;基质效应84.9%~92.1%,RSD<5%;回收率>80.0%。口服葛兰心宁软胶囊,绞股蓝皂苷A在大鼠体内的药代动力学参数t max为0.75 h,t 1/2为(6.247±2.039)h,药时曲线下面积(AUC)为(2562±252)μg·L^-1·h^-1。结论:绞股蓝皂苷A的药动学行为特征为口服快速吸收、达峰时间快、快速消除。 Objective:An in vivo method for the determination of gypenoside A in Glanxinning soft capsules was established by ultra-high performance liquid chromatography-mass spectrometry(UPLC-MS).Methods:The plasma concentration of gypenoside A in rats was determined by UPLC-MS after intragastric administration of Glanxinning soft capsule.The pharmacokinetic parameters of gypenoside A in rats were calculated by DAS 3.0 software.Results:The results showed that the linear range was 10-500 ng·mL^-1(r=0.9984);RSD was 2.7%,2.6%and 4.2%in high,medium and low concentrations;RSD was 2.4%,2.8%and 3.1%in daytime;matrix effect was 84.9%-92.1%,RSD was less than 5%;recovery was more than 80.0%.The oral pharmacokinetic parameters of gypenoside A in rats were T max 0.75 h,t 1/2 of(6.247±2.039)h,and AUC of(2562±252)μg·L^-1·h^-1.Conclusion:The results showed that the pharmacokinetic characteristics of gypenoside A were fast absorption,distribution,peak time and elimination.
作者 胡小虎 孙文军 高昕 王夕静 HU Xiao-hu;SUN Wen-jun;GAO Xin;WANG Xi-jing(Xi′an Chiho Pharmaceutical Co.,Ltd.,Xi′an 710075,China;Xi′an Xintong Pharmaceutical Research Co.,Ltd.,Xi′an 710077,China;School of Pharmacy,Xi′an Jiaotong University,Xi′an 710061,China)
出处 《中国现代中药》 CAS 2020年第7期1066-1071,共6页 Modern Chinese Medicine
关键词 绞股蓝皂苷A 药代动力学 液质联用 血药浓度 葛兰心宁软胶囊 gypenoside A pharmacokinetics LC-MS/MS blood concentration Glanxinning soft capsule
作者简介 通信作者:高昕,讲师,研究方向:基于系统生物学的中药化学标识物发现与鉴定,E-mail:gracegao@mail.xjtu.edu.cn。
  • 相关文献

参考文献5

二级参考文献30

  • 1梁红霞.葛根素注射液治疗冠心病疗效观察[J].医药论坛杂志,2000,8(12):48-49. 被引量:4
  • 2王俊,陈钧,杨克迪.测定穿山龙中薯蓣皂苷元的前处理方法的改进[J].中国药学杂志,2005,40(9):660-663. 被引量:11
  • 3刘丽健,刘永强,常艳茹,李庆杰,王本祥.GC-MS法测定薯蓣皂苷元大鼠血药浓度[J].药物分析杂志,2006,26(2):177-180. 被引量:6
  • 4卢金清,田耀平,曹阳,蒋胜军,黄芳,喻樊.HPLC-ELSD法测定绞股蓝中人参皂苷Rb_1的含量[J].中药材,2006,29(11):1190-1191. 被引量:9
  • 5全国中草药汇编编写组.全国中革药汇统编下册[M].北京:人民卫生出版,1978.467-468.
  • 6Chen J C,Lu K W,Tsal M L et al.Gypenosides Induced GO/G1 Arrest Via CHk2 and Apoptosis Through Endoplasmic Reticulum Stress and Mitochondria-Dependent Pathways in Human Tongue Cancer SCC-4 Cells[J].Oral Oncology,2009,45(3):273-283.
  • 7Kao T H,Huang S C,Stephen Inbaraj B et al.Determination of Flavonoidsand Saponins in Gynostemma Pentaphyllum (Thunb.)Makino by Liquid Chromatography-Mass Spectrometryanaly[J].Tica Chinica Acta,2008,626 (2):200-211.
  • 8陈可冀 廖家桢 肖镇祥.心脑血管病研究[M].上海:上海科技出版社,1988.311-313.
  • 9Yanagisa WM,Kurihara,Kinnra,et al.A novel potent vasoconstrictor peptides produced by vascular endothelial cells[J].Nature,1998,332(6163):411.
  • 10Ishekawa T,Yanagisawa M,Kimura S,et al.Positive inotropic action of a novel vasoconstrictor peptide endothelin on guinea pig atria[J].A m Heart J,1998,255:970.

共引文献31

同被引文献58

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部